“Successful Early Rescue With Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients With ‘No Washout Period’: A Real-World Clinical Experience in A Case Series and Literature Review”. Archives of Clinical and Medical Case Reports 10, no. 1 (January 9, 2026): 1–5. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/23020.